3.51
price down icon2.23%   -0.08
 
loading

Passage Bio Inc Stock (PASG) Forecast

The Passage Bio Inc (PASG) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $3.1791, representing a -9.43% decrease from the current price of $3.51. The highest analyst price target is $4.7105, and the lowest is $1.6476.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month PASG Price Target
Average 2.4334 (-30.67% Downside)
loading

Is Passage Bio Inc (PASG) A Buy Now?

Oscillators
Name Value Action
RSI(14) 36.27 Neutral
STOCH(9,6) 13.14 Buy
STOCHRSI(14) 41.03 Neutral
MACD(12,26) -0.2881 Sell
ADX(14) 15.72 Neutral
William %R -88.14 Buy
CCI(14) -28.26 Neutral
Buy: 2 Sell: 1 Neutral: 4
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
3.692
Sell
3.6952
Sell
MA20
3.9826
Sell
3.9293
Sell
MA50
4.4102
Sell
4.3152
Sell
MA100
4.6968
Sell
4.8604
Sell
MA200
6.6657
Sell
5.5726
Sell
Buy: 0 Sell: 10 Neutral: 0
Summary: Sell
According to our latest analysis, PASG could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 11 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on PASG, as trading bearish markets can be challenging and may result in losses.
  1. RSI (Relative Strength Index): The RSI(14) value of 36.27 indicates that PASG is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 13.14 indicates that PASG is oversold. This indicates that PASG price is at or near the lowest level over a specified lookback period.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 41.03 indicates that PASG is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 15.72 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -28.26 indicates that PASG is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.

Long-term PASG price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Passage Bio Inc financial reports and earnings history, Passage Bio Inc (PASG) stock could reach $2.6625 by 2030, $11.55 by 2040 and $22.21 by 2050. See the projected annual prices until 2050 of the Passage Bio Inc stock below:

  • Passage Bio Inc (PASG) is expected to reach an average price of $6.5401 in 2035, with a high prediction of $6.6307 and a low estimate of $6.5676. This indicates an $86.33% rise from the last recorded price of $3.51.
  • Passage Bio Inc (PASG) stock is projected to chart a bullish course in 2040, with an average price target of $11.39, representing an $224.40% surge from its current level. The forecast ranges from a conservative $11.40 to a sky-high $11.55.
  • Our analysts predict Passage Bio Inc (PASG) to jump 376.85% by 2045, soaring from $16.85 to an average price of $16.74, potentially reaching $16.78. While $16.85 is the low estimate, the potential upside is significant.
  • Passage Bio Inc (PASG) stock is expected to climb by 2050, reaching an average of $22.35, a $536.78% jump from its current level. However, a wide range of estimates exists, with high and low targets of $22.21 and $22.51, respectively, highlighting the market's uncertainty.

Passage Bio Inc Stock (PASG) Year by Year Forecast

Passage Bio Inc Stock (PASG) Price Forecast for 2026

The predicted value for Passage Bio Inc (PASG) in 2026 is set at an average of $10.60. Estimates vary from a peak of $20.00 to a trough of $1.2042, indicating an +202.05% surge from the present price of $3.51.
Month Average Low High Change from today's price
November, 2026 $2.1426 $1.6476 $4.7105 -38.96%
December, 2026 $1.6347 $1.2042 $2.7031 -53.43%

Passage Bio Inc Stock (PASG) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Passage Bio Inc (PASG) is $1.7024, with a high forecast of $3.2486 and a low forecast of $0.1563. This indicates an -51.50% decrease from the last price of $3.51.
Month Average Low High Change from today's price
January, 2027 $0.2732 $0.1563 $1.6152 -92.22%
February, 2027 $0.9211 $0.3421 $0.2984 -73.76%
March, 2027 $2.0185 $1.6106 $1.8185 -42.49%
April, 2027 $1.7464 $1.8564 $1.6764 -50.25%
May, 2027 $2.6438 $1.7059 $2.5938 -24.68%
June, 2027 $3.0317 $3.0517 $2.9617 -13.63%
July, 2027 $2.2396 $2.5896 $2.3901 -36.19%
August, 2027 $2.527 $2.458 $2.3035 -28.01%
September, 2027 $2.5949 $2.7049 $2.5064 -26.07%
October, 2027 $2.8428 $2.6943 $2.6233 -19.01%
November, 2027 $3.4102 $3.1322 $3.2477 -2.84%
December, 2027 $3.3181 $3.3486 $3.2486 -5.47%

Passage Bio Inc Stock (PASG) Price Forecast for 2028

In 2028, Passage Bio Inc (PASG) is projected to reach an average price of $3.073, with a high projection of $3.2737 and a low estimate of $2.8723. This indicates an -12.45% fall from the last price of $3.51.
Month Average Low High Change from today's price
January, 2028 $3.2854 $3.237 $3.2654 -6.40%
February, 2028 $3.0833 $3.2633 $3.2249 -12.16%
March, 2028 $2.8912 $2.8723 $2.7812 -17.63%
April, 2028 $3.1192 $3.0002 $3.0206 -11.14%
May, 2028 $3.2065 $3.1676 $3.1165 -8.65%
June, 2028 $3.2144 $3.2744 $3.176 -8.42%
July, 2028 $3.2418 $3.2673 $3.1923 -7.64%
August, 2028 $3.2096 $3.2287 $3.2003 -8.56%
September, 2028 $3.2276 $3.279 $3.2087 -8.04%
October, 2028 $3.215 $3.1466 $3.1955 -8.40%
November, 2028 $3.2719 $3.2845 $3.2737 -6.78%
December, 2028 $3.3357 $3.2724 $3.2424 -4.97%

Passage Bio Inc Stock (PASG) Price Forecast for 2029

The 2029 price forecast for Passage Bio Inc Stock (PASG) is $2.7282 on average, with a high prediction of $3.3198 and a low estimate of $2.1367. This represents an -22.27% decrease from the previous price of $3.51.
Month Average Low High Change from today's price
January, 2029 $3.3231 $3.3187 $3.3198 -5.32%
February, 2029 $3.3161 $3.3172 $3.2507 -5.52%
March, 2029 $3.227 $3.2545 $3.2411 -8.06%
April, 2029 $2.7414 $2.9213 $3.0683 -21.90%
May, 2029 $2.7593 $2.8193 $2.8304 -21.39%
June, 2029 $2.0272 $2.4571 $2.7088 -42.24%
July, 2029 $2.3346 $2.1367 $2.2627 -33.49%
August, 2029 $2.3225 $2.4241 $2.3125 -33.83%
September, 2029 $2.2804 $2.3609 $2.312 -35.03%
October, 2029 $2.6378 $2.4888 $2.4578 -24.85%
November, 2029 $2.6058 $2.6457 $2.5762 -25.76%
December, 2029 $2.6902 $2.6046 $2.5931 -23.36%

Passage Bio Inc Stock (PASG) Price Forecast for 2030

Passage Bio Inc Stock (PASG) is expected to reach an average price of $2.6233 in 2030, with a high forecast of $2.7234 and a low forecast of $2.5231. This signifies an -25.26% decrease from the last price of $3.51.
Month Average Low High Change from today's price
January, 2030 $2.6043 $2.746 $2.6625 -25.80%
February, 2030 $2.7199 $2.7194 $2.6599 -22.51%
March, 2030 $2.7118 $2.7368 $2.7222 -22.74%
April, 2030 $2.1442 $2.7063 $2.7234 -38.91%
May, 2030 $2.5751 $2.5231 $2.5721 -26.64%
June, 2030 $2.59 $2.5309 $2.53 -26.21%
July, 2030 $2.6126 $2.5895 $2.5484 -25.57%
August, 2030 $2.5942 $2.6467 $2.6258 -26.09%
September, 2030 $2.7127 $2.7047 $2.6842 -22.72%
October, 2030 $2.6714 $2.6856 $2.6816 -23.89%
November, 2030 $2.5357 $2.5584 $2.639 -27.76%
December, 2030 $2.4446 $2.5329 $2.5358 -30.35%
$5.86
price down icon 0.68%
$8.10
price up icon 3.98%
$8.38
price up icon 0.12%
DNA DNA
$9.71
price down icon 3.00%
$11.85
price down icon 6.10%
$10.49
price down icon 2.24%
Cap:     |  Volume (24h):